medigraphic.com
SPANISH

Revista Mexicana de Trasplantes

ISSN 2007-6800 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number S1

<< Back Next >>

Rev Mex Traspl 2020; 9 (S1)

Immunological Risk Assessment

Morales-Buenrostro LE
Full text How to cite this article 10.35366/93478

DOI

DOI: 10.35366/93478
URL: https://dx.doi.org/10.35366/93478

Language: Spanish
References: 5
Page: 13-17
PDF size: 200.19 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Sellarés J, de Freitas DG, Mengel M et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012; 12 (2): 388-399.

  2. Haas M, Loupy A, Lefaucheur C et al. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018; 18 (2): 293-307.

  3. Jordan SC, Ammerman N, Choi J et al. Novel Therapeutic approaches to allosensitization and antibody-mediated rejection. Transplantation. 2019; 103 (2): 262-272.

  4. Morales-Buenrostro LE. Estudios inmunológicos en el receptor de trasplante renal. En: Morales-Buenrostro LE. Evaluación del riesgo inmunológico y terapia de inducción en trasplante renal. México: Graphimedic S.A. de C.V.; 2016. pp. 11-33.

  5. Morales-Buenrostro LE. Estratificación del riesgo inmunológico previo al trasplante. Criterios y evidencia científica. En: Morales-Buenrostro LE. Evaluación del riesgo inmunológico y terapia de inducción en trasplante renal. México: Graphimedic S.A. de C.V.; 2016. pp. 34-42.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Traspl. 2020;9